Invention Grant
US08173124B2 Method to treat using antagonistic anti-hTNFSF13b human antibodies 有权
使用拮抗性抗hTNFSF13b人抗体治疗的方法

  • Patent Title: Method to treat using antagonistic anti-hTNFSF13b human antibodies
  • Patent Title (中): 使用拮抗性抗hTNFSF13b人抗体治疗的方法
  • Application No.: US12777306
    Application Date: 2010-05-11
  • Publication No.: US08173124B2
    Publication Date: 2012-05-08
  • Inventor: Kristine Kay Kikly
  • Applicant: Kristine Kay Kikly
  • Applicant Address: US IN Indianapolis
  • Assignee: Eli Lilly and Company
  • Current Assignee: Eli Lilly and Company
  • Current Assignee Address: US IN Indianapolis
  • Agent Sanjay Jivraj
  • Main IPC: A61K39/395
  • IPC: A61K39/395
Method to treat using antagonistic anti-hTNFSF13b human antibodies
Abstract:
Human monoclonal antibodies that specifically bind to TNFSF13b polypeptides are disclosed. These antibodies have high affinity for hTNFSF13b (e.g., KD=10−8 M or less), a slow off rate for TNFSF13b dissociation (e.g., Koff=10−3 sec−1 or less) and neutralize TNFSF13b activity in vitro and in vivo. The antibodies of the invention are useful in one embodiment for inhibiting TNFSF13b activity in a human subject suffering from a disorder in which hTNFSF13b activity is detrimental. Nucleic acids encoding the antibodies of the present invention, as well as, vectors and host cells for expressing them are also encompassed by the invention.
Public/Granted literature
Information query
Patent Agency Ranking
0/0